期刊文献+

HLA配型不合造血干细胞移植术后免疫功能重建及其与发生感染的关系 被引量:1

Clinical study on immune reconstitution and infection after HLA-mismatched hematopoietic stem cell transplantation
下载PDF
导出
摘要 目的观察HLA配型不合造血干细胞移植术后免疫功能重建及感染的情况。方法选择14例接受HLA配型不合造血干细胞移植患者,分别以淋巴细胞亚群、血清球蛋白含量、移植后感染的情况为观察指标,监测移植后免疫功能与感染的关系。结果患者移植后表现为CD4+和CD19+长期的减少,CD4+/CD8+的持续倒置,IgA恢复最慢。移植后1个月内感染率高,6个月后感染发病率减少。结论HLA配型不合造血干细胞移植术后患者免疫功能的恢复需要数月至数年的时间,控制间质性肺炎及重症感染是降低感染病死率的关键。 Objective To observe the immune reconstititution and the infection condition after HLA-mismatched hernatopoietic stern cell transplantation. Methods Forteen patients accepted the transplantation, and the lymphocytes immunity pheocyte, serum globulin level and infection states were analyzed. Results CD4^+ ana CD19^+ obviously decreased and CD4^+/CD8^+ continuously inversed. IgA level 2ecovered slowly. Infection rate at the first stage after transplatation was high and was decreaasesd 6 months later. Conclusion After HLA-mismatched hematopoietic stern cell transplanta- tion the recovery of immune function of the patients needs months to yeans. The key for reducing death rate after infection is to control interstitial pneumonia and severe infection.
出处 《江苏医药》 CAS CSCD 北大核心 2007年第5期445-446,共2页 Jiangsu Medical Journal
关键词 造血干细胞移植 免疫重建 感染 Hematopoietic stern cell transplantation Immunity reconstititution Infection
  • 相关文献

参考文献2

二级参考文献12

  • 1Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med, 1993, 328: 593-602.
  • 2Beatty PG. Marrow transplantation using volunteer unrelated donors in a comparison of mismatched family donor transplants:a Seattle perspective. Bone Marrow Transplant, 1994, 14 Suppl 4: S39-41.
  • 3Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med,1998, 339: 1186-1193.
  • 4Mineishi S, Longo WL, Atkinson ME, et al. Addition of highdose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. Bone Marrow Transplant, 1999, 23: 1217-1222.
  • 5Hassan HT,Stockschlader M,Schleimer B,et al. Comparison of the content and subpopulation of CD3 and CD34 positive cells in bone marrow harvest and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors. Transplant Immunol, 1996,
  • 6Mielcarek M, Roecklein BA, Torok-Storb B. CD14+- cells in GCSF mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood,1996, 87: 574-580.
  • 7Pan L, Delmonte J Jr, Jalonen CK, et al. Pretreatment of donor mice with granulocyte-colony stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood, 1995,86 :
  • 8Arpinati M, Loken M, Anasetti C. G-CSF mobilizes type 2-derdritic cells rather than type 1-dendritic cells. Blood, 1998, 92Suppl 1: 111a.
  • 9Ji SQ, Chen HR, Wang HX, et al. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Biol Blood Marrow Tran
  • 10Ji SQ, Chen HR, Xun CQ, et al. The effect of G-CSF stimulated donor marrow on engraftment and incidence of graft-versushost disease in allogeneic bone marrow transplantation. Clin Transplant, 2001, 15: 317-323.

共引文献67

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部